Identify the dispensing pharmacy and read the regulatory record.

Our MEDVi review separates what the provider currently publishes from what still needs a personal quote or clinical assessment. Sources were checked September 19, 2026; advertised availability and pricing can change.

The quick read

  • Identify the dispensing pharmacy and read the regulatory record.
  • We did not verify a universal current GLP-1 total from the reviewed home page. The exact medication, duration, pharmacy and subsequent charge should be on the written offer. A low introductory campaign elsewhere should not substitute for that information.
  • Which legal entity provides my care, which pharmacy compounds my prescription, and what documented response addresses the cited FDA concerns?

What the current public pages establish

MEDVi’s current home page describes online clinician-led care, GLP-1 treatment, support and pharmacy fulfillment. Its disclosures say MEDVi is not acting as a pharmacy and identify separate pharmacy partners. Promotional patient counts and testimonials do not establish independently measured outcomes.

This review concerns the public offer at the sources below, checked September 19, 2026. It is not a patient-experience review. We have not enrolled, obtained a prescription, contacted the care team as a patient or measured service quality. Where a detail remains unconfirmed, we leave it open rather than filling it from an old comparison.

What the price includes—and what to confirm

We did not verify a universal current GLP-1 total from the reviewed home page. The exact medication, duration, pharmacy and subsequent charge should be on the written offer. A low introductory campaign elsewhere should not substitute for that information.

For a usable quote, write down the amount due today, payment interval, medication quantity, length of the commitment and next renewal. Add consultation, ongoing care, laboratory, shipping and pharmacy charges wherever they are separate. Our GLP-1 cost guide explains how to put those amounts on the same basis.

The decision that deserves a closer look

FDA published a February 20, 2026 warning letter addressed to MEDVi, LLC dba MEDVi, citing medvi.io marketing and misleading impressions about who compounded the drugs and their relationship to approved products. Our current commercial-page check was at home.medvi.org. Confirm the contracting entity and request its response; the historical letter alone does not establish the present resolution of FDA’s concerns.

Before the consultation

Bring one specific question to MEDVi: Which legal entity provides my care, which pharmacy compounds my prescription, and what documented response addresses the cited FDA concerns?

Also ask who will be prescribing, which pharmacy will dispense, how you reach the clinical team, and who handles a delayed shipment or a problem with the label. Request the payment and cancellation terms in writing. A customer-support promise and a clinical appointment are different services, so confirm how each works. Our first appointment guide can help you prepare your medical history and existing medication list.

Prescription and evidence boundaries

A provider listing is not a prescription or an endorsement of a particular treatment. Compounded products are not FDA-approved, and evidence for an approved medicine does not automatically establish the safety or effectiveness of another formulation. See the compounded-versus-approved guide for those distinctions.

Use the exact medication and route when discussing suitability with your clinician. Ask the dispensing pharmacy to explain its label, storage directions and what to do if delivery conditions are questionable. General website instructions should not replace the instructions for your own prescription.

Compare the care you would actually receive

Use the same questions with another service before deciding. The CoreAge Rx review describes our featured commercial partner, and the Embody review explores another care or payment model. CoreAge Rx’s featured placement is commercial and does not establish clinical superiority.

Compare the complete written offers, the kind of clinician access you want, and the plan for follow-up. If a provider cannot clarify the medicine, the total payment obligation or who is responsible for continuing care, resolve those questions before enrolling. The provider verification guide gives you a practical next step.

Sources & reading notes

Public materials checked September 19, 2026. Provider pages establish advertised terms, not independent proof of outcomes or service quality. Clinical information is general and is not personal medical advice. No clinician review of this article is claimed.

  1. MEDVi — official program page
  2. FDA warning letter to MEDVi, LLC dba MEDVi — February 20, 2026
  3. FDA: concerns about unapproved GLP-1 drugs
  4. FDA BeSafeRx: online pharmacy information

How we research · How commercial placement works